- Home
- CURI vs SCLX Comparison
CURI vs SCLX Comparison
Compare CURI & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- SCLX
- Stock Information
- Founded
- CURI 2015
- SCLX 2011
- Country
- CURI United States
- SCLX United States
- Employees
- CURI N/A
- SCLX N/A
- Industry
- CURI Movies/Entertainment
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- SCLX Health Care
- Exchange
- CURI Nasdaq
- SCLX Nasdaq
- Market Cap
- CURI 100.4M
- SCLX 81.7M
- IPO Year
- CURI N/A
- SCLX N/A
- Fundamental
- Price
- CURI $1.54
- SCLX $0.45
- Analyst Decision
- CURI Strong Buy
- SCLX Strong Buy
- Analyst Count
- CURI 1
- SCLX 3
- Target Price
- CURI $3.00
- SCLX $11.33
- AVG Volume (30 Days)
- CURI 168.1K
- SCLX 184.3K
- Earning Date
- CURI 11-06-2024
- SCLX 12-31-2024
- Dividend Yield
- CURI 6.49%
- SCLX N/A
- EPS Growth
- CURI N/A
- SCLX N/A
- EPS
- CURI N/A
- SCLX N/A
- Revenue
- CURI $51,775,000.00
- SCLX $50,833,000.00
- Revenue This Year
- CURI N/A
- SCLX $32.77
- Revenue Next Year
- CURI $9.18
- SCLX $50.71
- P/E Ratio
- CURI N/A
- SCLX N/A
- Revenue Growth
- CURI N/A
- SCLX 9.41
- 52 Week Low
- CURI $0.45
- SCLX $0.43
- 52 Week High
- CURI $3.00
- SCLX $2.63
- Technical
- Relative Strength Index (RSI)
- CURI 37.16
- SCLX 31.02
- Support Level
- CURI $1.47
- SCLX $0.48
- Resistance Level
- CURI $1.72
- SCLX $0.54
- Average True Range (ATR)
- CURI 0.09
- SCLX 0.05
- MACD
- CURI -0.01
- SCLX -0.01
- Stochastic Oscillator
- CURI 18.42
- SCLX 5.81
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.